SCHEMBL4632389

SCHEMBL4632389

CCc1[nH]nc(O)c1Cc1c(F)cc(OC)cc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.41
GRK6 P43250 2/20 0.35
TTR P02766 1/20 0.34
USP7 Q93009 1/20 0.32
SMPD3 Q9NY59 1/20 0.32
HCAR2 Q8TDS4 1/20 0.32
ADORA2A P29274 2/20 0.32
ADORA1 P30542 1/20 0.32
P2RX7 Q99572 2/20 0.31
MEN1 O00255 1/20 0.31
GAA P10253 1/20 0.31
KMT2A Q03164 1/20 0.31
TGFBR1 P36897 1/20 0.31
CCNB2 O95067 1/20 0.31
CCNE2 O96020 1/20 0.31
CDK1 P06493 1/20 0.31
CDK4 P11802 1/20 0.31
CCNB1 P14635 1/20 0.31
CCND1 P24385 1/20 0.31
CCNE1 P24864 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3770602 0.83 TAAR1 (0.42) TAAR1GRK6TTRP2RX7MEN1
SCHEMBL4633267 0.80 DBH (0.34) TTRSMPD3HCAR2ADORA2AP2RX7
SCHEMBL13073165 0.69 TAAR1 (0.63) TAAR1USP7KMT2ATRAP1HSP90B1
SCHEMBL3779266 0.68 ALDH1A1 (0.42) P2RX7MEN1GAAKMT2AALDH1A1
SCHEMBL4633441 0.67 P2RX7 (0.40) TTRHCAR2P2RX7
SCHEMBL3769458 0.65 MAPT (0.41) ADORA2AADORA1MEN1GAAKMT2A
SCHEMBL3776543 0.64 TAAR1 (0.61) TAAR1ALDH1A1
SCHEMBL16518659 0.63 TAAR1 (0.55) TAAR1USP7TRAP1ALDH1A1HPGD
SCHEMBL13548269 0.63 TAAR1 (0.70) TAAR1CCNB2CDK1CCNB1CCNB3
SCHEMBL16693753 0.62 TAAR1 (0.53) TAAR1USP7MEN1KMT2ATRAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912656-A2 METHODS FOR PREVENTING AND TREATING METABOLIC DISORDERS AND NEW PYRAZOLE-O-GLYCOSIDE DERIVATIVES Boehringer Ingelheim International GmbH (DE) 2008-04-23 EP disclosed
WO-2007014895-A2 METHODS FOR PREVENTING AND TREATING METABOLIC DISORDERS AND NEW PYRAZOLE-O-GLYCOSIDE DERIVATIVES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-02-08 WO disclosed